153 related articles for article (PubMed ID: 21112821)
1. N-Myc is a downstream target of RET signaling and is required for transcriptional regulation of p18(Ink4c) by the transforming mutant RET(C634R).
Kulkarni MV; Franklin DS
Mol Oncol; 2011 Feb; 5(1):24-35. PubMed ID: 21112821
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.
van Veelen W; van Gasteren CJ; Acton DS; Franklin DS; Berger R; Lips CJ; Höppener JW
Cancer Res; 2008 Mar; 68(5):1329-37. PubMed ID: 18316595
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
5. N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.
Zindy F; Knoepfler PS; Xie S; Sherr CJ; Eisenman RN; Roussel MF
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11579-83. PubMed ID: 16864777
[TBL] [Abstract][Full Text] [Related]
6. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
Forget A; Ayrault O; den Besten W; Kuo ML; Sherr CJ; Roussel MF
Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828
[TBL] [Abstract][Full Text] [Related]
7. Expression of p27
Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of RET with multiple endocrine neoplasia type 2.
Zhang M; Liu Y; Fu J; Hu Y; Sun Z
J Cancer Res Ther; 2017; 13(5):823-828. PubMed ID: 29237911
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
Lindberg D; Akerström G; Westin G
Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
[TBL] [Abstract][Full Text] [Related]
10. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
Georgitsi M
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
[TBL] [Abstract][Full Text] [Related]
11. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
[TBL] [Abstract][Full Text] [Related]
12. A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.
Bagheri-Yarmand R; Sinha KM; Gururaj AE; Ahmed Z; Rizvi YQ; Huang SC; Ladbury JE; Bogler O; Williams MD; Cote GJ; Gagel RF
J Biol Chem; 2015 May; 290(18):11749-61. PubMed ID: 25795775
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
[TBL] [Abstract][Full Text] [Related]
14. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
[TBL] [Abstract][Full Text] [Related]
15. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.
Segouffin-Cariou C; Billaud M
J Biol Chem; 2000 Feb; 275(5):3568-76. PubMed ID: 10652352
[TBL] [Abstract][Full Text] [Related]
16. Absence of cyclin-dependent kinase inhibitor p27 or p18 increases efficiency of iPSC generation without induction of iPSC genomic instability.
Zhan Z; Song L; Zhang W; Gu H; Cheng H; Zhang Y; Yang Y; Ji G; Feng H; Cheng T; Li Y
Cell Death Dis; 2019 Mar; 10(4):271. PubMed ID: 30894510
[TBL] [Abstract][Full Text] [Related]
17. Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma.
Cuccuru G; Lanzi C; Cassinelli G; Pratesi G; Tortoreto M; Petrangolini G; Seregni E; Martinetti A; Laccabue D; Zanchi C; Zunino F
J Natl Cancer Inst; 2004 Jul; 96(13):1006-14. PubMed ID: 15240784
[TBL] [Abstract][Full Text] [Related]
18. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
[TBL] [Abstract][Full Text] [Related]
19. The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.
Iervolino A; Iuliano R; Trapasso F; Viglietto G; Melillo RM; Carlomagno F; Santoro M; Fusco A
Cancer Res; 2006 Jun; 66(12):6280-7. PubMed ID: 16778204
[TBL] [Abstract][Full Text] [Related]
20. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]